Company Profiles

driven by the PitchBook Platform

Remedy Pharmaceuticals

Description

Developer of small molecule drugs designed to help people with central nervous system related edema for surviving life to the fullest. The company's small molecule drugs including CIRARA, target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries, enabling patients with central nervous system disorders to lead a healthy life.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$9M

Latest Deal Amount

$15.3M

Total Amount Raised

Description

Developer of small molecule drugs designed to help people with central nervous system related edema for surviving life to the fullest. The company's small molecule drugs including CIRARA, target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries, enabling patients with central nervous system disorders to lead a healthy life.

Website:

www.remedypharmaceuticals.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

233 Broadway 17th Floor New York, NY 10279United States +1 (212) 586-2226
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Remedy Pharmaceuticals's full profile, request a free trial.

Remedy Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Remedy Pharmaceuticals Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
Broadview VenturesVenture CapitalMinority000 0000000 0000
Carrot Capital Healthcare VenturesVenture CapitalMinority000 0000000 0000
Edgar S. WoolardAngel (individual)Minority000 0000000 0000
Eric A. PottsAngel (individual)Minority000 0000000 0000
Biosciences Research and Commercialization Center Venture Capital
Broadview Ventures Venture Capital
Carrot Capital Healthcare Ventures Venture Capital
Edgar S. Woolard Angel (individual)
Eric A. Potts Angel (individual)

Remedy Pharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Richard SteinhartChief Financial Officer
Thomas MacAllister JDVice President, Research & Development & General Counsel
Ann Tunstall Ph.DVice President, Regulatory And Clinical Operations
Sven JacobsonCo-Founder, Chief Executive Officer & Board Member
Richard Steinhart Chief Financial Officer
Thomas MacAllister JD Vice President, Research & Development & General Counsel
Ann Tunstall Ph.D Vice President, Regulatory And Clinical Operations
Sven Jacobson Co-Founder, Chief Executive Officer & Board Member

Remedy Pharmaceuticals Board Members (10)

NameRepresentingRoleSinceContact
Info
Charles MeleSelfBoard Member & Advisor000 0000
David EpsteinRemedy PharmaceuticalsBoard Member000 0000
David GeliebterCarrot Capital Healthcare VenturesManaging Director & Senior Partner000 0000
Edgar WoolardRemedy PharmaceuticalsBoard Member000 0000
Eric Potts MDRemedy PharmaceuticalsBoard Member000 0000
Charles Mele Board Member & Advisor Self
David Epstein Board Member Remedy Pharmaceuticals
David Geliebter Managing Director & Senior Partner Carrot Capital Healthcare Ventures
Edgar Woolard Board Member Remedy Pharmaceuticals
Eric Potts MD Board Member Remedy Pharmaceuticals
Request full access to PitchBook